HealthWatchlist verdict: Peppermint oil for nausea has mixed evidence. Some newer trials report short-term benefit after surgery or during chemotherapy, while earlier pooled results and a pregnancy trial were negative. It should be considered, if at all, alongside appropriate care rather than as a replacement for anti-sickness treatment.
Three settings that should not be merged
Nausea after an anaesthetic, nausea during chemotherapy and sickness in pregnancy have different treatment contexts. Evidence from one setting does not automatically answer the others.
The route also matters. Most aroma studies involve inhalation, but some papers test an oral preparation or a mixture of oils. A general claim that “peppermint works” leaves too much unspecified.
Why the older review was cautious
The Cochrane review of postoperative nausea included a peppermint-specific comparison. Four small trials, involving 115 participants, did not establish a reduction in nausea severity five minutes after treatment compared with placebo.
The evidence was rated low quality. This is uncertainty about a defined early outcome, not proof that every peppermint intervention is ineffective. Findings about isopropyl alcohol in the same review are not peppermint findings.
A newer review of postoperative prevention studies reported reduced nausea severity. However, vomiting results were not statistically significant and overall certainty was low. Its different oils, protocols and outcomes limit a direct comparison with the earlier review.
Recent surgical trials add information
A 106-person gynaecological surgery trial compared inhaled peppermint with saline. The reported 24-hour incidence of postoperative nausea or vomiting was 52.8% versus 73.6%.
That positive result concerns a supervised perioperative protocol and a combined outcome. It does not show that inhaling peppermint at home prevents vomiting from any cause.
An oral-surgery study tested peppermint, ginger and lavender together. Although 182 patients were randomised, the reported intervention involved the smaller subset who developed postoperative nausea.
Nausea severity improved, but the comparison of antiemetic use was not significant. The study also cannot identify which ingredient contributed. It is a blend trial, not a peppermint-only replication.
A rhinoplasty trial used an oral peppermint preparation. It reported less nausea but no significant difference in vomiting or pain. Because the route differs, it should not be counted as evidence for inhaled peppermint.
None of these protocols is a reason to swallow aromatherapy oil. A specified research preparation and a retail bottle are not interchangeable.
Chemotherapy studies need their standard treatment context
An open-label, quasi-randomised chemotherapy pilot reported improvement in several treatment groups. Participants also received routine antiemetics, and the cisplatin subgroup did not show the same benefit.
The study therefore suggests an adjunctive possibility with important design limits. It does not establish that peppermint can replace prescribed medicines or works consistently across chemotherapy regimens.
A separate 79-person study compared a peppermint-scented damp cloth with an unscented cloth. It reported reduced nausea intensity. The abstract does not describe random allocation, so it should not be presented as a definitive randomised trial.
A 2026 review of four breast-cancer trials found a possible reduction in acute nausea. Certainty was low, vomiting evidence was very low, and the included interventions were not all inhaled peppermint.
The review explicitly supports continuing guideline-based antiemetic care. Short-term comfort and prevention of serious treatment-related sickness are different standards of evidence.
Pregnancy findings are not uniformly positive
A placebo-controlled trial in 56 pregnant women found no significant between-group benefit. Symptoms improved in both groups over four days.
A before-and-after improvement alone would have made peppermint look effective. The comparison shows why a control group matters, especially when symptoms naturally fluctuate.
| Setting | Current reading |
|---|---|
| After surgery | Some positive newer trials; low-certainty and inconsistent findings overall. |
| During chemotherapy | Possible adjunctive nausea relief, with important formulation and design limits. |
| Pregnancy | Peppermint alone did not outperform placebo in the cited trial. |
Using the findings safely
NCCIH summarises peppermint’s benefits and risks by preparation. Tea, enteric-coated medicines and aromatherapy oil require separate decisions. Do not give concentrated oil by mouth or expose an infant’s face to menthol-rich products.
Ask the surgical or cancer-care team before using an aroma product. Stop if the smell worsens nausea or causes coughing, headache or breathing discomfort. Scents should also respect other people in shared rooms.
NHS advice recommends assessment for persistent or recurring nausea. Sudden nausea with heavy chest pain, spreading pain or shortness of breath needs emergency help. Repeated vomiting and dehydration also require appropriate care.
Evidence score
John’s Evidence Score: 3/10 for peppermint inhalation as an adjunct for nausea. This editorial judgement reflects positive signals without consistent evidence across settings.
A useful future trial would measure meaningful symptom relief and rescue medicine use, keep standard care consistent, and report both benefits and adverse effects clearly.
How this review was researched
Research checked on 14 September 2026. We searched PubMed for the named oils or preparations and the condition, reviewed the retrieved study abstracts and relevant reviews, and checked the official guidance linked below. This is an editorial review, not an exhaustive systematic review. We distinguish human treatment outcomes from laboratory findings, and identify where a study tested a mixture or a different preparation.
Related reading
- Peppermint oil profile
- Nausea and motion sickness overview
- Ginger preparations for nausea
- Lemon aroma and pregnancy sickness
- Why IBS capsule evidence is different
References
- Aromatherapy for treatment of postoperative nausea and vomiting.
- Aromatherapy for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis.
- Effect of inhaled peppermint essential oil aromatherapy on postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery.
- Effect of aromatherapy with peppermint, ginger, and lavender on postoperative nausea severity after oral surgery under general anaesthesia: A single-blind randomized controlled trial.
- The effect of peppermint essential oil on postoperative nausea, vomiting, and pain in rhinoplasty patients: a randomized clinical trial.
- The Effects of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy: An Open Label Quasi-Randomized Controlled Pilot Study.
- Peppermint Oil: Evaluating Efficacy on Nausea in Patients Receiving Chemotherapy in the Ambulatory Setting.
- Essential oil-based interventions for chemotherapy-induced nausea and vomiting in women with breast cancer: a systematic review and meta-analysis.
- Effect of Aromatherapy with Peppermint Oil on the Severity of Nausea and Vomiting in Pregnancy: A Single-blind, Randomized, Placebo-controlled trial.
- NCCIH: Peppermint oil
- NHS: Feeling sick (nausea)